כניסה 
עקבו אחרינו בפייסבוק קוד ATC code - ATC
מפתח קודי ATC
גישה מהירה A / B / C / D / G / H / J / L / M / N / P / R / S / V
- הטבלא ניתנת למיון לפי כל אחת מהעמודות
|- | |A06 | | | |Drugs for constipation |- | | |A06A | | |Drugs for constipation |- | | | |A06AA | |Softeners, emollients |- | | | | |A06AA01 |Liquid paraffin |- | | | | |A06AA02 |Docusate sodium |- | | | | |A06AA51 |Liquid paraffin, combinations |- | | | |A06AB | |Contact laxatives |- | | | | |A06AB01 |Oxyphenisatine |- | | | | |A06AB02 |Bisacodyl |- | | | | |A06AB03 |Dantron |- | | | | |A06AB04 |Phenolphthalein |- | | | | |A06AB05 |Castor oil |- | | | | |A06AB06 |Senna glycosides |- | | | | |A06AB07 |Cascara |- | | | | |A06AB08 |Sodium picosulfate |- | | | | |A06AB09 |Bisoxatin |- | | | | |A06AB20 |Contact laxatives in combination |- | | | | |A06AB30 |Contact laxatives in combination with belladonna alkaloids |- | | | | |A06AB52 |Bisacodyl, combinations |- | | | | |A06AB53 |Dantron, combinations |- | | | | |A06AB56 |Senna glycosides, combinations |- | | | | |A06AB57 |Cascara, combinations |- | | | | |A06AB58 |Sodium picosulfate, combinations |- | | | |A06AC | |Bulk-forming laxatives |- | | | | |A06AC01 |Ispaghula (psylla seeds) |- | | | | |A06AC02 |Ethulose |- | | | | |A06AC03 |Sterculia |- | | | | |A06AC05 | Linseed |- | | | | |A06AC06 |Methylcellulose |- | | | | |A06AC07 |Triticum (wheat fibre) |- | | | | |A06AC08 |Polycarbophil calcium |- | | | | |A06AC51 |Ispaghula, combinations |- | | | | |A06AC53 |Sterculia, combinations |- | | | | |A06AC55 |Linseed, combinations |- | | | |A06AD | |Osmotically acting laxatives |- | | | | |A06AD01 |Magnesium carbonate |- | | | | |A06AD02 |Magnesium oxide |- | | | | |A06AD03 |Magnesium peroxide |- | | | | |A06AD04 |Magnesium sulfate |- | | | | |A06AD10 |Mineral salts in combination |- | | | | |A06AD11 |Lactulose |- | | | | |A06AD12 |Lactitol |- | | | | |A06AD13 |Sodium sulfate |- | | | | |A06AD14 |Pentaerithrityl |- | | | | |A06AD15 |Macrogol |- | | | | |A06AD16 |Mannitol |- | | | | |A06AD17 |Sodium phosphate |- | | | | |A06AD18 |Sorbitol |- | | | | |A06AD19 |Magnesium citrate |- | | | | |A06AD21 |Sodium tartrate |- | | | | |A06AD61 |Lactulose, combinations |- | | | | |A06AD65 |Macrogol, combinations |- | | | |A06AG | |Enemas |- | | | | |A06AG01 |Sodium phosphate |- | | | | |A06AG02 |Bisacodyl |- | | | | |A06AG03 |Dantron, including combinations |- | | | | |A06AG04 |Glycerol |- | | | | |A06AG06 |Oil |- | | | | |A06AG07 |Sorbitol |- | | | | |A06AG10 |Docusate sodium, including combinations |- | | | | |A06AG11 |Laurilsulfate, including combinations |- | | | | |A06AG20 |Combinations |- | | | |A06AH | |Peripheral opioid receptor antagonists |- | | | | |A06AH01 |Methylnaltrexone bromide |- | | | | |A06AH02 |Alvimopan |- | | | |A06AX | |Other drugs for constipation |- | | | | |A06AX01 |Glycerol |- | | | | |A06AX02 |Carbon dioxide producing drugs |- | | | | |A06AX03 |Lubiprostone |- | | | | |A06AX04 |Linaclotide |- | | | | |A06AX05 |Prucalopride |- | | | | |A06AX06 |Tegaserod |- | |A07 | | | |Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |- | | | | | |להשלים |- | |A08 | | | |Antiobesity preparations, excluding diet products |- | | | | | |להשלים |- | |A09 | | | |Digestives,including enzymes |- | | | | | |להשלים |- | |A10 | | | |Drugs used in diabetes |- | | |A10A | | |Insulins and analogues |- | | | |A10AB | |Insulins and analogues for injection, fast-acting |- | | | | |A10AB01 |Insulin (human) |- | | | | |A10AB02 |Insulin (beef) |- | | | | |A10AB03 |Insulin (pork) |- | | | | |A10AB04 |Insulin lispro |- | | | | |A10AB05 |Insulin aspart |- | | | | |A10AB06 |Insulin glulisine |- | | | | |A10AB30 |Combinations |- | | | |A10AC | |Insulins and analogues for injection, intermediate-acting |- | | | | |A10AC01 |Insulin (human) |- | | | | |A10AC02 |Insulin (beef) |- | | | | |A10AC03 |Insulin (pork) |- | | | | |A10AC04 |Insulin lispro |- | | | | |A10AC30 |Combinations |- | | | |A10AD | |Insulins and analogues for injection, intermediate-acting combined with fast-acting |- | | | | |A10AD01 |Insulin (human) |- | | | | |A10AD02 |Insulin (beef) |- | | | | |A10AD03 |Insulin (pork) |- | | | | |A10AD04 |Insulin lispro |- | | | | |A10AD05 |Insulin aspart |- | | | | |A10AD30 |Combinations |- | | | |A10AE | |Insulins and analogues for injection, long-acting |- | | | | |A10AE01 |Insulin (human) |- | | | | |A10AE02 |Insulin (beef) |- | | | | |A10AE03 |Insulin (pork) |- | | | | |A10AE04 |Insulin glargine |- | | | | |A10AE05 |Insulin detemir |- | | | | |A10AE30 |Combinations |- | | | |A10AF | |Insulins and analogues for inhalation |- | | | | |A10AF01 |Insulin (human) |- | | |A10B | | |Blood glucose lowering drugs, excluding insulins |- | | | |A10BA | |Biguanides |- | | | | |A10BA01 |Phenformin |- | | | | |A10BA02 |Metformin |- | | | | |A10BA03 |Buformin |- | | | |A10BB | |Sulfonamides, urea derivatives |- | | | | |A10BB01 |Glibenclamide |- | | | | |A10BB02 |Chlorpropamide |- | | | | |A10BB03 |Tolbutamide |- | | | | |A10BB04 |Glibornuride |- | | | | |A10BB05 |Tolazamide |- | | | | |A10BB06 |Carbutamide |- | | | | |A10BB07 |Glipizide |- | | | | |A10BB08 |Gliquidone |- | | | | |A10BB09 |Gliclazide |- | | | | |A10BB10 |Metahexamide |- | | | | |A10BB11 |Glisoxepide |- | | | | |A10BB12 |Glimepiride |- | | | | |A10BB31 |Acetohexamide |- | | | |A10BC | |Sulfonamides (heterocyclic) |- | | | | |A10BC01 |Glymidine |- | | | |A10BD | |Combinations of oral blood glucose lowering drugs |- | | | | |A10BD01 |Phenformin and sulfonamides |- | | | | |A10BD02 |Metformin and sulfonamides |- | | | | |A10BD03 |Metformin and rosiglitazone |- | | | | |A10BD04 |Glimepiride and rosiglitazone |- | | | | |A10BD05 |Metformin and pioglitazone |- | | | | |A10BD06 |Glimepiride and pioglitazone |- | | | | |A10BD07 |Metformin and sitagliptin |- | | | | |A10BD08 |Metformin and vildagliptin |- | | | | |A10BD09 |Pioglitazone and alogliptin |- | | | | |A10BD10 |Metformin and saxagliptin |- | | | | |A10BD11 |Metformin and linagliptin |- | | | | |A10BD12 |Pioglitazone and sitagliptin |- | | | | |A10BD13 |Metformin and alogliptin |- | | | |A10BF | |Alpha glucosidase inhibitors |- | | | | |A10BF01 |Acarbose |- | | | | |A10BF02 |Miglitol |- | | | | |A10BF03 |Voglibose |- | | | |A10BG | |Thiazolidinediones |- | | | | |A10BG01 |Troglitazone |- | | | | |A10BG02 |Rosiglitazone |- | | | | |A10BG03 |Pioglitazone |- | | | |A10BH | |Dipeptidyl peptidase 4 (DPP-4) inhibitors |- | | | | |A10BH01 |Sitagliptin |- | | | | |A10BH02 |Vildagliptin |- | | | | |A10BH03 |Saxagliptin |- | | | | |A10BH04 |Alogliptin |- | | | | |A10BH05 |Linagliptin |- | | | | |A10BH51 |Sitagliptin and simvastatin |- | | | |A10BX | |Other blood glucose lowering drugs, excluding insulins |- | | | | |A10BX01 |Guar gum |- | | | | |A10BX02 |Repaglinide |- | | | | |A10BX03 |Nateglinide |- | | | | |A10BX04 |Exenatide |- | | | | |A10BX05 |Pramlintide |- | | | | |A10BX06 |Benfluorex |- | | | | |A10BX07 |Liraglutide |- | | | | |A10BX08 |Mitiglinide |- | | | | |A10BX09 |Dapagliflozin |- | | |A10X | | |Other drugs used in diabetes |- | | | |A10XA | |Aldose reductase inhibitors |- | | | | |A10XA01 |Tolrestat |- | |A11 | | | |Vitamins |- | | | | | |להשלים |- | |A12 | | | |Mineral supplements |- | | |A12A | | |ֻCalcium |- | | | | | |להשלים |- | | |A12B | | |Potassium |- | | | | | |להשלים |- | | |A12C | | |Other mineral supplements |- | | | |A12CA | |Sodium |- | | | | | |להשלים |- | | | |A12CB | |Zinc |- | | | | | |להשלים |- | | | |A12CC | |Magnesium |- | | | | | |להשלים |- | | | |A12CD | |Fluoride |- | | | | | |להשלים |- | | | |A12CE | |Selenium |- | | | | | |להשלים |- | | | |A12CX | |Other mineral products |- | | | | | |להשלים |- | |A13 | | | |Tonics |- | | |A13A | | |Tonics |- | | | | | |empty |- | |A14 | | | |Anabolic agents for systemic use |- | | | | | |להשלים |- | |A15 | | | |Appetite stimulants |- | | | | | |empty |- | |A16 | | | |Other alimentary tract and metabolism products |- | | | | | |להשלים |- |B | | | | |Blood and blood forming organs |- | |B01 | | | |Antithrombotic agents |- | | |B01A | | |Antithrombotic agents |- | | | |B01AA | |Vitamin K antagonists |- | | | | |B01AA01 |Dicoumarol |- | | | | |B01AA02 |Phenindione |- | | | | |B01AA03 |Warfarin |- | | | | |B01AA04 |Phenprocoumon |- | | | | |B01AA07 |Acenocoumarol |- | | | | |B01AA08 |Ethyl biscoumacetate |- | | | | |B01AA09 |Clorindione |- | | | | |B01AA10 |Diphenadione |- | | | | |B01AA11 |Tioclomarol |- | | | | |B01AA12 |Fluindione |- | | | |B01AB | |Heparin group |- | | | | |B01AB01 |Heparin |- | | | | |B01AB02 |Antithrombin III |- | | | | |B01AB04 |Dalteparin |- | | | | |B01AB05 |Enoxaparin |- | | | | |B01AB06 |Nadroparin |- | | | | |B01AB07 |Parnaparin |- | | | | |B01AB08 |Reviparin |- | | | | |B01AB09 |Danaparoid |- | | | | |B01AB10 |Tinzaparin |- | | | | |B01AB11 |Sulodexide |- | | | | |B01AB12 |Bemiparin |- | | | | |B01AB51 |Heparin, combinations |- | | | |B01AC | |Platelet aggregation inhibitors excluding heparin |- | | | | |B01AC01 |Ditazole |- | | | | |B01AC02 |Cloricromen |- | | | | |B01AC03 |Picotamide |- | | | | |B01AC04 |Clopidogrel |- | | | | |B01AC05 |Ticlopidine |- | | | | |B01AC06 |Acetylsalicylic acid |- | | | | |B01AC07 |Dipyridamole |- | | | | |B01AC08 |Carbasalate calcium |- | | | | |B01AC09 |Epoprostenol |- | | | | |B01AC10 |Indobufen |- | | | | |B01AC11 |Iloprost |- | | | | |B01AC13 |Abciximab |- | | | | |B01AC15 |Aloxiprin |- | | | | |B01AC16 |Eptifibatide |- | | | | |B01AC17 |Tirofiban |- | | | | |B01AC18 |Triflusal |- | | | | |B01AC19 |Beraprost |- | | | | |B01AC21 |Treprostinil |- | | | | |B01AC22 |Prasugrel |- | | | | |B01AC23 |Cilostazol |- | | | | |B01AC24 |Ticagrelor |- | | | | |B01AC30 |Combinations |- | | | | |B01AC56 |Acetylsalicylic acid and esomeprazole |- | | | |B01AD | |Enzymes |- | | | | |B01AD01 |Streptokinase |- | | | | |B01AD02 |Alteplase |- | | | | |B01AD03 |Anistreplase |- | | | | |B01AD04 |Urokinase |- | | | | |B01AD05 |Fibrinolysin |- | | | | |B01AD06 |Brinase |- | | | | |B01AD07 |Reteplase |- | | | | |B01AD08 |Saruplase |- | | | | |B01AD09 |Ancrod |- | | | | |B01AD10 |Drotrecogin alfa (activated) |- | | | | |B01AD11 |Tenecteplase |- | | | | |B01AD12 |Protein C |- | | | |B01AE | |Direct thrombin inhibitors |- | | | | |B01AE01 |Desirudin |- | | | | |B01AE02 |Lepirudin |- | | | | |B01AE03 |Argatroban |- | | | | |B01AE04 |Melagatran |- | | | | |B01AE05 |Ximelagatran |- | | | | |B01AE06 |Bivalirudin |- | | | | |B01AE07 |Dabigatran etexilate |- | | | |B01AF | |Direct factor Xa inhibitors |- | | | | |B01AF01 |Rivaroxaban |- | | | | |B01AF02 |Apixaban |- | | | |B01AX | |Other antithrombotic agents |- | | | | |B01AX01 |Defibrotide |- | | | | |B01AX04 |Dermatan sulfate |- | | | | |B01AX05 |Fondaparinux |- | |B02 | | | |Antihemorrhagics |- | |B03 | | | |Antianemic preparations |- | |B05 | | | |Blood substitutes and perfusion solutions |- | | |B05A | | |Blood and related products |- | | | |B05AA | |Blood substitutes and plasma protein fractions |- | | | | |B05AA01 |Serum albumin |- | | | | |B05AA02 |Other plasma protein fractions |- | | | | |B05AA03 |Fluorocarbon blood substitutes |- | | | | |B05AA05 |Dextran |- | | | | |B05AA06 |Gelatin agents |- | | | | |B05AA07 |Hydroxyethylstarch |- | | | | |B05AA08 |Hemoglobin crosfumaril |- | | | | |B05AA09 |Hemoglobin raffimer |- | | | | |B05AA10 |Hemoglobin glutamer (bovine) |- | | | |B05AX | |Other blood products |- | | | | |B05AX01 |Erythrocytes |- | | | | |B05AX02 |Thrombocytes |- | | | | |B05AX03 |Blood plasma |- | | | | |B05AX04 |Stem cells from umbilical cord blood |- | | |B05B | | |I.v. solutions |- | | | |B05BA | |Solutions for parenteral nutrition |- | | | | |B05BA01 |Amino acids |- | | | | |B05BA02 |Fat emulsions |- | | | | |B05BA03 |Carbohydrates |- | | | | |B05BA04 |Protein hydrolysates |- | | | | |B05BA10 |Combinations |- | | | |B05BB | |Solutions affecting the electrolyte balance |- | | | | |B05BB01 |Electrolytes |- | | | | |B05BB02 |Electrolytes with carbohydrates |- | | | | |B05BB03 |Trometamol |- | | | | |B05BB04 |Electrolytes in combination with other drugs |- | | | |B05BC | |Solutions producing osmotic diuresis |- | | | | |B05BC01 |Mannitol |- | | | | |B05BC02 |Carbamide |- | | |B05C | | |Irrigating solutions |- | | | |B05CA | |Antiinfectives |- | | | | |B05CA01 |Cetylpyridinium |- | | | | |B05CA02 |Chlorhexidine |- | | | | |B05CA03 |Nitrofural |- | | | | |B05CA04 |Sulfamethizole |- | | | | |B05CA05 |Taurolidine |- | | | | |B05CA06 |Mandelic acid |- | | | | |B05CA07 |Noxytiolin |- | | | | |B05CA08 |Ethacridine lactate |- | | | | |B05CA09 |Neomycin |- | | | | |B05CA10 |Combinations |- | | | |B05CB | |Salt solutions |- | | | | |B05CB01 |Sodium chloride |- | | | | |B05CB02 |Sodium citrate |- | | | | |B05CB03 |Magnesium citrate |- | | | | |B05CB04 |Sodium bicarbonate |- | | | | |B05CB10 |Combinations |- | | | |B05CX | |Other irrigating solutions |- | | | | |B05CX01 |Glucose |- | | | | |B05CX02 |Sorbitol |- | | | | |B05CX03 |Glycine |- | | | | |B05CX04 |Mannitol |- | | | | |B05CX10 |Combinations |- | | |B05D | | |Peritoneal dialytics |- | | | |B05DA | |Isotonic solutions |- | | | |B05DB | |Hypertonic solutions |- | | |B05X | | |I.v. solution additives |- | | | |B05XA | |Electrolyte solutions |- | | | | |B05XA01 |Potassium chloride |- | | | | |B05XA02 |Sodium bicarbonate |- | | | | |B05XA03 |Sodium chloride |- | | | | |B05XA04 |Ammonium chloride |- | | | | |B05XA05 |Magnesium sulfate |- | | | | |B05XA06 |Potassium phosphate, including combinations with other potassium salts |- | | | | |B05XA07 |Calcium chloride |- | | | | |B05XA08 |Sodium acetate |- | | | | |B05XA09 |Sodium phosphate |- | | | | |B05XA10 |Magnesium phosphate |- | | | | |B05XA11 |Magnesium chloride |- | | | | |B05XA12 |Zinc chloride |- | | | | |B05XA13 |Hydrochloric acid |- | | | | |B05XA14 |Sodium glycerophosphate |- | | | | |B05XA15 |Potassium lactate |- | | | | |B05XA16 |Cardioplegia solutions |- | | | | |B05XA17 |Potassium acetate |- | | | | |B05XA30 |Combinations of electrolytes |- | | | | |B05XA31 |Electrolytes in combination with other drugs |- | | | |B05XB | |Amino acids |- | | | | |B05XB01 |Arginine hydrochloride |- | | | | |B05XB02 |Alanyl glutamine |- | | | | |B05XB03 |Lysine |- | | | |B05XC | |Vitamins |- | | | |B05XX | |Other i.v. solution additives |- | | | | |B05XX02 |Trometamol |- | | |B05Z | | |Hemodialytics and hemofiltrates |- | | | |B05ZA | |Hemodialytics, concentrates |- | | | |B05ZB | |Hemofiltrates |- | |B06 | | | |Other hematological agents |- |C | | | | |Cardiovascular system |- | |C01 | | | |Cardiac therapy |- | |C02 | | | |Antihypertensives |- | |C03 | | | |Diuretics |- | |C04 | | | |Peripheral vasodilators |- | |C05 | | | |Vasoprotectives |- | |C07 | | | |Beta blocking agents |- | |C08 | | | |Calcium channel blockers |- | |C09 | | | |Agents acting on the renin-angiotensin system |- | |C10 | | | |Lipid modifying agents |- | | |C10A | | |Lipid modifying agents, plain |- | | | |C10AA | |HMG CoA reductase inhibitors |- | | | |C10AB | |Fibrates |- | | | |C10AC | |Bile acid sequestrants |- | | | | | C10AC01 |Colestyramine |- | | | | |C10AC02 |Colestipol |- | | | | | C10AC03 |Colextran |- | | | | |C10AC04 |Colesevelam |- | | | |C10AD | |Nicotinic acid and derivatives |- | | | |C10AX | |Other lipid modifying agents |- | | |C10B | | |Lipid modifying agents, combinations |- |D | | | | |Dermatologicals |- | |D01 | | | |Antifungals for dermatological use |- | |D02 | | | |Emollients and protectives |- | |D03 | | | |Preparations for treatment of wounds and ulcers |- | |D04 | | | |Antipruritics, including antihistamines, anesthetics, etc |- | |D05 | | | |Antipsoriatics |- | |D06 | | | |Antibiotics and chemotherapeutics for dermatological use |- | |D07 | | | |Corticosteroids, dermatological preparations |- | |D08 | | | |Antiseptics and disinfectants |- | |D09 | | | |Medicated dressings |- | |D10 | | | |Anti-acne preparations |- | |D11 | | | |Other dermatological preparations |- |G | | | | |Genito-urinary system and sex hormones |- | |G01 | | | |Gynecological antiinfectives and antiseptics |- | |G02 | | | |Other gynecologicals |- | |G03 | | | |Sex hormones and modulators of the genital system |- | |G04 | | | |Urologicals |- | | |G04B | | |Urologicals |- | | | |G04BA | |Acidifiers |- | | | |G04BC | |Urinary concrement solvents |- | | | |G04BD | |Drugs for urinary frequency and incontinence |- | | | | |G04BD01 |Emepronium |- | | | | |G04BD02 |Flavoxate |- | | | | |G04BD03 |Meladrazine |- | | | | |G04BD04 |Oxybutynin |- | | | | |G04BD05 |Terodiline |- | | | | |G04BD06 |Propiverine |- | | | | |G04BD07 |Tolterodine |- | | | | |G04BD08 |Solifenacin |- | | | | |G04BD09 |Trospium |- | | | | |G04BD10 |Darifenacin |- | | | | |G04BD11 |Fesoterodine |- | | | | |G04BD12 |Mirabegron |- | | | |G04BE | |Drugs used in erectile dysfunction |- | | | | |G04BE01 |Alprostadil |- | | | | |G04BE02 |Papaverine |- | | | | |G04BE03 |Sildenafil |- | | | | |G04BE04 |Yohimbin |- | | | | |G04BE06 |Moxisylyte |- | | | | |G04BE07 |Apomorphine |- | | | | |G04BE08 |Tadalafil |- | | | | |G04BE09 |Vardenafil |- | | | | |G04BE30 |Combinations |- | | | | |G04BE52 |Papaverine, combinations |- | | | |G04BX | |Other urologicals |- | | | | | |להשלים |- | | |G04C | | |Drugs used in benign prostatic hypertrophy |- | | | |G04CA | |Alpha-adrenoreceptor antagonists |- | | | |G04CB | |Testosterone-5-alpha reductase inhibitors |- | | | |G04CX | |Other drugs used in benign prostatic hypertrophy |- |H | | | | |Systemic hormonal preparations, excluding sex hormones and insulins |- | |H01 | | | |Pituitary and hypothalamic hormones and analogues |- | |H02 | | | |Corticosteroids for systemic use |- | |H03 | | | |Thyroid therapy |- | |H04 | | | |Pancreatic hormones |- | |H05 | | | |Calcium homeostasis |- |J | | | | |Antiinfectives for systemic use |- | |J01 | | | |Antibacterials for systemic use |- | | |J01A | | |Tetracyclines |- | | |J01B | | |Amphenicols |- | | |J01C | | |Beta-lactam antibacterials, penicillins |- | | |J01D | | |Other beta-lactam antibacterials |- | | |J01E | | |Sulfonamides and trimethoprim |- | | |J01F | | |Macrolides, lincosamides and streptogramins |- | | |J01G | | |Aminoglycoside antibacterials |- | | |J01M | | |Quinolone antibacterials |- | | |J01R | | |Combinations of antibacterials |- | | |J01X | | |Other antibacterials |- | | | |J01XA | |Glycopeptide antibacterials |- | | | |J01XB | |Polymyxins |- | | | |J01XC | |Steroid antibacterials |- | | | |J01XD | |Imidazole derivatives |- | | | |J01XE | |Nitrofuran derivatives |- | | | | J01XX | |Other antibacterials |- | |J02 | | | |Antimycotics for systemic use |- | |J04 | | | |Antimycobacterials |- | |J05 | | | |Antivirals for systemic use |- | | |J05A | | |Direct acting antiviral drugs |- | | | |J05AA | |Thiosemicarbazones |- | | | |J05AB | |Nucleosides and nucleotides excluding reverse transcriptase inhibitors |- | | | |J05AC | |Cyclic amines |- | | | |J05AD | |Phosphonic acid derivatives |- | | | |J05AE | |Protease inhibitors |- | | | |J05AF | |Nucleoside and nucleotide reverse transcriptase inhibitors |- | | | | |J05AF01 | Zidovudine |- | | | | |J05AF02 | Didanosine |- | | | | |J05AF03 | Zalcitabine |- | | | | |J05AF04 | Stavudine |- | | | | |J05AF05 | Lamivudine |- | | | | |J05AF06 | Abacavir |- | | | | |J05AF07 | Tenofovir disoproxil |- | | | | |J05AF08 | Adefovir dipivoxil |- | | | | |J05AF09 | Emtricitabine |- | | | | |J05AF10 | Entecavir |- | | | | |J05AF11 | Telbivudine |- | | | | |J05AF12 | Clevudine |- | | | |J05AG | |Non-nucleoside reverse transcriptase inhibitors |- | | | | |J05AG01 |Nevirapine |- | | | | |J05AG02 |Delavirdine |- | | | | |J05AG03 |Efavirenz |- | | | | |J05AG04 |Etravirine |- | | | | |J05AG05 |Rilpivirine |- | | | |J05AH | |Neuraminidase inhibitors |- | | | | |J05AH01 |Zanamivir |- | | | | |J05AH02 |Oseltamivir |- | | | |J05AR | |Antivirals for treatment of HIV infections, combinations |- | | | | |J05AR01 |Zidovudine and lamivudine |- | | | | |J05AR02 |Lamivudine and abacavir |- | | | | |J05AR03 |Tenofovir disoproxil and emtricitabine |- | | | | |J05AR04 |Zidovudine, lamivudine and abacavir |- | | | | |J05AR05 |Zidovudine, lamivudine and nevirapine |- | | | | |J05AR06 |Emtricitabine, tenofovir disoproxil and efavirenz |- | | | | |J05AR07 |Stavudine, lamivudine and nevirapine |- | | | | |J05AR08 |Emtricitabine, tenofovir disoproxil and rilpivirine |- | | | | |J05AR09 |Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat |- | | | | |J05AR10 |Lopinavir and ritonavir |- | | | |J05AX | |Other antivirals |- | | | | |J05AX01 |Moroxydine |- | | | | |J05AX02 |Lysozyme |- | | | | |J05AX05 |Inosine pranobex |- | | | | |J05AX06 |Pleconaril |- | | | | |J05AX07 |Enfuvirtide |- | | | | |J05AX08 |Raltegravir |- | | | | |J05AX09 |Maraviroc |- | | | | |J05AX10 |Maribavir |- | | | | |J05AX11 |Elvitegravir |- | |J06 | | | |Immune sera and immunoglobulins |- | | |J06A | | | Immune sera |- | | | |J06AA | | Immune sera |- | | | | |J06AA01 | Diphtheria antitoxin |- | | | | | J06AA02 | Tetanus antitoxin |- | | | | |J06AA03 | Snake venom antiserum |- | | | | | J06AA04 | Botulinum antitoxin |- | | | | |J06AA05 | Gas-gangrene sera |- | | | | | J06AA06 | Rabies serum |- | | |J06B | | | Immunoglobulins |- | | | |J06BA | |Immunoglobulins, normal human |- | | | | |J06BA01 |Immunoglobulins, normal human, for extravascular administration |- | | | | | J06BA02 |Immunoglobulins, normal human, for intravascular administration |- | | | |J06BB | |Specific immunoglobulins |- | | | | |J06BB01 |Anti-D (rh) immunoglobulin |- | | | | |J06BB02 | Tetanus immunoglobulin |- | | | | |J06BB03 | Varicella/zoster immunoglobulin |- | | | | |J06BB04 | Hepatitis B immunoglobulin |- | | | | |J06BB05 | Rabies immunoglobulin |- | | | | | J06BB06 | Rubella immunoglobulin |- | | | | | J06BB07 | Vaccinia immunoglobulin |- | | | | |J06BB08 | Staphylococcus immunoglobulin |- | | | | | J06BB09 | Cytomegalovirus immunoglobulin |- | | | | |J06BB10 | Diphtheria immunoglobulin |- | | | | |J06BB11 | Hepatitis A immunoglobulin |- | | | | |J06BB12 | Encephalitis, tick borne immunoglobulin |- | | | | |J06BB13 | Pertussis immunoglobulin |- | | | | |J06BB14 |Morbilli immunoglobulin |- | | | | |J06BB15 | Parotitis immunoglobulin |- | | | | |J06BB16 | Palivizumab |- | | | | | J06BB17 | Motavizumab |- | | | | |J06BB30 | Combinations |- | | | |J06BC | | Other immunoglobulins |- | | | | |J06BC01 | Nebacumab |- |L | | | | |Antineoplastic and immunomodulating agents |- | |L01 | | | |Antineoplastic agents |- | |L02 | | | |Endocrine therapy |- | |L03 | | | |Immunostimulants |- | |L04 | | | |Immunosuppressants |- |M | | | | |Musculo-skeletal system |- | |M01 | | | |Anti-inflammatory and antirheumatic products |- | | |M01A | | |Anti-inflammatory and antirheumatic products, non-steroids |- | | | |M01AA | |Butylpyrazolidines |- | | | |M01AB | |Acetic acid derivatives and related substances |- | | | | | M01AB01 | Indometacin |- | | | | | M01AB02 | Sulindac |- | | | | | M01AB03 | Tolmetin |- | | | | | M01AB04 | Zomepirac |- | | | | | M01AB05 | Diclofenac |- | | | | | M01AB06 | Alclofenac |- | | | | | M01AB07 | Bumadizone |- | | | | | M01AB08 | Etodolac |- | | | | | M01AB09 | Lonazolac |- | | | | | M01AB10 | Fentiazac |- | | | | | M01AB11 | Acemetacin |- | | | | | M01AB12 | Difenpiramide |- | | | | | M01AB13 | Oxametacin |- | | | | | M01AB14 | Proglumetacin |- | | | | | M01AB15 | Ketorolac |- | | | | | M01AB16 | Aceclofenac |- | | | | | M01AB17 | Bufexamac |- | | | | | M01AB51 | Indometacin, combinations |- | | | | | M01AB55 | Diclofenac, combinations |- | | | |M01AC | |Oxicams |- | | | |M01AE | |Propionic acid derivatives |- | | | |M01AG | |Fenamates |- | | | |M01AH | |Coxibs |- | | | |M01AX | |Other anti-inflammatory and antirheumatic agents, non-steroids |- | | | | |M01AX01 |Nabumetone |- | | | | |M01AX02 |Niflumic acid |- | | | | |M01AX04 |Azapropazone |- | | | | |M01AX05 |Glucosamine |- | | | | |M01AX07 |Benzydamine |- | | | | |M01AX12 |Glucosaminoglycan polysulfate |- | | | | |M01AX13 |Proquazone |- | | | | |M01AX14 |Orgotein |- | | | | |M01AX17 |Nimesulide |- | | | | |M01AX18 |Feprazone |- | | | | |M01AX21 |Diacerein |- | | | | |M01AX22 |Morniflumate |- | | | | |M01AX23 |Tenidap |- | | | | |M01AX24 |Oxaceprol |- | | | | |M01AX25 |Chondroitin sulfate |- | | | | |M01AX26 |Avocado and soyabean oil, unsaponifiables |- | | | | |M01AX68 |Feprazone, combinations |- | | |M01B | | |Anti-inflammatory/antirheumatic agents in combination |- | | |M01C | | |Specific antirheumatic agents |- | |M02 | | | |Topical products for joint and muscular pain |- | | |M02A | | |Topical products for joint and muscular pain |- | | | |M02AA | |Anti-inflammatory preparations, non-steroids for topical use |- | | | | |M02AA01 |Phenylbutazone |- | | | | |M02AA02 |Mofebutazone |- | | | | |M02AA03 |Clofezone |- | | | | |M02AA04 |Oxyphenbutazone |- | | | | |M02AA05 |Benzydamine |- | | | | |M02AA06 |Etofenamate |- | | | | |M02AA07 |Piroxicam |- | | | | |M02AA08 |Felbinac |- | | | | |M02AA09 |Bufexamac |- | | | | |M02AA10 |Ketoprofen |- | | | | |M02AA11 |Bendazac |- | | | | |M02AA12 |Naproxen |- | | | | |M02AA13 |Ibuprofen |- | | | | |M02AA14 |Fentiazac |- | | | | |M02AA15 |Diclofenac |- | | | | |M02AA16 |Feprazone |- | | | | |M02AA17 |Niflumic acid |- | | | | |M02AA18 |Meclofenamic acid |- | | | | |M02AA19 |Flurbiprofen |- | | | | |M02AA21 |Tolmetin |- | | | | |M02AA22 |Suxibuzone |- | | | | |M02AA23 |Indometacin |- | | | | |M02AA24 |Nifenazone |- | | | | |M02AA25 |Aceclofenac |- | | | | |M02AA26 |Nimesulide |- | | | |M02AB | |Capsaicin and similar agents |- | | | |M02AC | |Preparations with salicylic acid derivatives |- | | | |M02AX | |Other topical products for joint and muscular pain |- | |M03 | | | |Muscle relaxants |- | |M04 | | | |Antigout preparations |- | |M05 | | | |Drugs for treatment of bone diseases |- | |M09 | | | |Other drugs for disorders of the musculo-skeletal system |- |N | | | | |Nervous system |- | |N01 | | | | Anesthetics |- | |N02 | | | | Analgesics |- | |N03 | | | | Antiepileptics |- | |N04 | | | |Anti-parkinson drugs |- | |N05 | | | | Psycholeptics |- | | |N05A | | | Antipsychotics |- | | | |N05AA | |Phenothiazines with aliphatic side-chain |- | | | |N05AB | |Phenothiazines with piperazine structure |- | | | |N05AC | |Phenothiazines with piperidine structure |- | | | |N05AD | |Butyrophenone derivatives |- | | | |N05AE | |Indole derivatives |- | | | |N05AF | |Thioxanthene derivative |- | | | |N05AG | |Diphenylbutylpiperidine derivatives |- | | | |N05AH | |Diazepines, oxazepines, thiazepines and oxepines |- | | | |N05AL | |Benzamides |- | | | |N05AN | |Lithium |- | | | |N05AX | |Other antipsychotics |- |- | | | | | N05AX07 |Prothipendyl |- | | | | |N05AX08 |Risperidone |- | | | | |N05AX10 |Mosapramine |- | | | | |N05AX11 |Zotepine |- | | | | |N05AX12 |Aripiprazole |- | | | | |N05AX13 |Paliperidone |- | | | | |N05AX14 |Iloperidone |- | | |N05B | | | Anxiolytics |- | | |N05C | | | Hypnotics and sedatives |- | |N06 | | | | Psychoanaleptics |- | |N07 | | | | Other nervous system drugs |- |P | | | | |Antiparasitic products, insecticides and repellents |- | |P01 | | | |Antiprotozoals |- | |P02 | | | |Anthelmintics |- | |P03 | | | |Ectoparasiticides, including scabicides, insecticides and repellents |- |R | | | | |Respiratory system |- | |R01 | | | |Nasal preparations |- | |R02 | | | |Throat preparations |- | |R03 | | | |Drugs for obstructive airway diseases |- | |R05 | | | |Cough and cold preparations |- | |R06 | | | |Antihistamines for systemic use |- | |R07 | | | |Other respiratory system products |- |S | | | | |Sensory organs |- | |S01 | | | | Ophthalmologicals |- | |S02 | | | |Otologicals |- | |S03 | | | |Ophthalmological and otological preparations |- |V | | | | |Various |- | |V01 | | | |Allergens |- | |V03 | | | |All other therapeutic products |- | |V04 | | | |Diagnostic agents |- | |V06 | | | |General nutrients |- | |V07 | | | |All other non-therapeutic products |- | |V08 | | | |Contrast media |- | |V09 | | | |Diagnostic radiopharmaceuticals |- | |V10 | | | |Therapeutic radiopharmaceuticals |- | |V20 | | | |Surgical dressings |}